Drug production value blood and body fluid agents Japan 2016, by category
The statistic illustrates the drug production value of blood and body fluid agents in Japan in 2016, broken down by sub therapeutic category. In the surveyed period, anticoagulants accounted for the largest share of the blood and body fluid agents production value in Japan, with around 133 billion Japanese yen, followed by blood substitutes with about 68 billion yen.